Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting
European Journal of Nuclear Medicine and Molecular Imaging · 2026-04 · 53 (5) · 3034-3041
DOI: 10.1007/s00259-025-07682-5 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 28.11.2025. Verfasst von Florian Rosar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Dipeptides, Prostatic Neoplasms, Castration-Resistant, Lutetium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
- Department of Nuclear Medicine, Marburg University - Campus Fulda, Fulda, Germany.
- Department of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany. samer.ezziddin@uks.eu.
- Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, D-66421, Homburg, Germany. samer.ezziddin@uks.eu.
ORCID-Profile: Samer Ezziddin
Zitieren
APA
Rosar, F., Khreish, F., Burgard, C., Fursov, A., Blickle, A., Bartholomä, M., Maus, S., Bastian, M. B., Speicher, T., Schaefer-Schuler, A., & Ezziddin, S. (2026). Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting. European Journal of Nuclear Medicine and Molecular Imaging, 53(5), 3034-3041. https://doi.org/10.1007/s00259-025-07682-5
Vancouver
Rosar F, Khreish F, Burgard C, Fursov A, Blickle A, Bartholomä M, et al. Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(5):3034-3041. doi:10.1007/s00259-025-07682-5
BibTeX
@article{Rosar2026,
author = {Rosar, Florian and Khreish, Fadi and Burgard, Caroline and Fursov, Artyom and Blickle, Arne and Bartholomä, Mark and Maus, Stephan and Bastian, Moritz B and Speicher, Tilman and Schaefer-Schuler, Andrea and Ezziddin, Samer},
title = {Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {5},
pages = {3034--3041},
doi = {10.1007/s00259-025-07682-5}
}
EUVIMED